Literature DB >> 32843048

Dynamic hip screws versus cannulated screws for femoral neck fractures: a systematic review and meta-analysis.

Lang Li1, Xue Zhao2, Xiaodong Yang1, Xueyang Tang1, Ming Liu3.   

Abstract

OBJECTIVE: Dynamic hip screw (DHS) and cannulated screws (CS) are widely used for femoral neck fractures. However, there is no definite result as to which surgical method bring less complications. We performed this study to compare the complication (mortality, non-union, avascular necrosis (AVN), and revision) of DHS and CS for the treatment of femoral neck fractures patients.
METHODS: We searched Pubmed, Ovid, Cochrane Central Register of Controlled Trials, and other relevant studies related the comparison of DHS versus CS for femoral neck fractures from inception to Jan 7, 2020. The quality of the included randomized controlled trials (RCTs) and retrospective studies were assessed using the Cochrane Collaboration tool and Newcastle-Ottawa (NOS), respectively. The meta-analysis was performed by the RevMan 5.2 software.
RESULTS: Nine RCTs and seven retrospective cohort studies were included for meta-analysis. CS was found to be superior to DHS with respect to AVN rate (OR 1.47; 95% CI 1.08-1.99; p = 0.01, I2 = 0%). There were no significant between-group differences with respect to mortality, non-union, and revision (p > 0.05).
CONCLUSION: DHS and CS have similar complication including mortality, revision rate, and non-union, but CS has superior to DHS on ANV. However, further studies are required to provide more robust evidence owing to some limitations.

Entities:  

Keywords:  Cannulated screws; Dynamic hip screw; Femoral neck fractures; Meta-analysis

Mesh:

Year:  2020        PMID: 32843048      PMCID: PMC7449015          DOI: 10.1186/s13018-020-01842-z

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


Introduction

Femoral neck fractures are common fractures in the orthopedics department, and incidence of femoral neck fracture increased with the increase of population ages and traffic accidents. Previous study reported that for young adult patients, the incidence of femoral neck fractures amounted to 0.04%. However, the incidence for older patients is increase to 0.28~0.64% [1, 2]. In the past, due to the limited treatment methods for femoral neck fracture, it has been considered as “unresolved fracture” [3]. Previous studies reported that femoral neck fractures are associated with complications such as avascular necrosis (AVN), non-union, implant failure/revision, and even death [4, 5]. There are many options to treat femoral neck fracture. Previous studies reported that femoral neck fractures with following surgery are associated implant failure [6, 7]. Multiple cannulated screws (CS) and dynamic hip screw (DHS) are widely used for non-displaced or young patients. CS has better biomedical properties such as anti-rotation and less invasive, which was widely used in non-displaced intracapsular fractures [6, 8]. DHS could maintain the neck-shaft angle and anatomical reduction, which is helpful for fracture fixation [7]. Lee et al. reported that DHS has a higher rate of overall success when compared to the MCS group [9]. However, a recent study showed no significant difference between two treatments on rates of revision surgery and complications [10]. In addition, systematic review or meta-analysis is also conducted in previous studies [8, 11]. However, whether CS is superior to DHS was not consistent. Moreover, some limitations exist in previous studies: the sample size of the studies included is small sample size with only RCTs included, which could lead to selection bias. Publication bias is not analyzed before. In the current study, we performed a systematic review and meta-analysis to compare the complication of DHS and CS for femoral neck fracture. This study aimed to provide an evidence for treatment of femoral neck fractures for surgeon.

Materials and methods

Eligibility criteria and literature search

According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA) checklist and flow diagram [12], studies that compared DHS and CS for femoral neck fractures were searched in online databases such as Cochrane Central Register of Controlled Trials, Pubmed, and Ovid. Studies published from initial to Jan 7, 2020 were enrolled for inclusion. The following medical subject heading (Mesh) was used for searching “femoral neck fractures,” “femur,” “hip,” “dynamic,” “sliding,” “cannulated,” “cancellous,” and “intracapsular.” The search was limited to language of English. A hand search was also performed to avoid missing additional relevant trials by screening the reference lists of all the selected articles. The inclusion criteria for this meta-analysis were (1) patients: adult patients diagnosed with femoral neck fracture; (2) intervention: patients treated by DHS (or CS); (3) comparison treatment: patients treated by CS (or DHS); (4) outcomes: mortality, non-union, AVN, and revision; 5) study design: RCTs, prospective, and retrospective were all included; the exclusion criteria were (1) duplicate publications, meta-analysis, systematic reviews, and case reports; (2) studies for whom full text was not available; (3) pathological fractures; and (4) studies presenting data that were incomplete and/or could not be extracted were excluded.

Outcomes of interest, data extraction, and quality assessment

The interest outcome for this meta-analysis was mortality, non-union, AVN, and revision rate. Two reviewers independently screened the titles and abstracts according to the selection criteria, and any disagreements were discussed. The study design, country, age, gender, type of implant, follow-up, and outcomes were independently extracted by two reviewers. The quality of included RCTs was assessed by Cochrane Collaboration recommendations [13], and retrospective studies were assessed by Newcastle-Ottawa (NOS) [14]. For RCTs, random sequence generation (selection bias), allocation concealment (selection bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias), and other sources of bias were assessed. For retrospective studies, a total of nine scores including the selection, comparability, and outcome were assessed. When the score was greater than 7 points, the quality of the retrospective studies was considered high.

Statistical analysis

All data were analyzed using the Review Manager software (Version 5.2, The Nordic Cochrane Centre, The Cochrane Collaboration, 2012). The odd ratio (OR) and 95% CI were calculated for dichotomous outcomes. Fixed-effect models and random-effect models were used when I2 < 50% and I2 > 50%, respectively. And when I2 > 50%, the sensitivity analysis or subgroup was conducted. Publication bias was also conducted by Review Manager (version 5.2). A P value of < .05 was considered statistically significant.

Results

Characteristics and qualities of the studies included

A total of 319 studies were retrieved, and 240 studies remained after duplication. After screening abstract full text, sixteen studies (nine RCTs and seven retrospective cohort studies) were included for meta-analysis, which was shown in Fig. 1. There were 2657 hips analyzed in the sixteen studies: 1337 hips for DHS and 1320 hips for CS. The full text of sixteen studies was available, and the basic characteristics of included studies were shown in Table 1. There was a moderate risk bias for the RCTs: four studies mentioned random sequence regeneration [17, 18, 23, 27], six studies mentioned allocation concealment [17, 18, 23–26], two studies used the blinding of participants [17, 18], one study used observed blinding [17], eight studies reported complete outcome [17, 18, 20, 21, 23, 24, 26, 27], and nine studies reported all outcome date without reporting bias [17, 18, 20, 21, 23–27]. For retrospective cohort studies, three studies had 9 scores [9, 10, 28], two studies had 8 scores [15, 19], and two studies had 7 scores [16, 22]. The details were shown in Fig. 2 and Table 2.
Fig. 1

Flow diagram of the selection process of the studies included for the meta-analysis

Table 1

Characteristics of the studies included

Included studyCountryTypeMean age (year)Hips analyzed(DHS/CS)gender(Male/female)InterventionsFollow-upOutcome
Lee 2007 [9]TaiwanRetrospective72.8/70.640/4435/49DHS vs multiple cannulated screws12①②③④
Widhalm 2019 [10]UKRetrospective76.9(18-100)254/199110/343DHS vs double cannulated screw24①②③④
Watson 2012 [15]AustraliaRCT77.9(53-89)/76.7(53-93)31/2911/49DHS vs Cancellous screws24①②③④
Sharma 2018 [16]IndiaRCTNA(21-57)27/29-DHS vs Cancellous screws24②③
FAITH 2017 [17]CanadaRCT72.2±12.0/72±12.3542/537422/648SHS vs Cancellous screws24①②③④
Gupta 2016 [18]IndiaRCT40.7(16-60)/39.3(16-60)40/4555/30SHS vs multiple cancellous screws12 to 36①②③④
Sørensen 1992 [19]DenmarkRCT77(52-94)35/3818/55SHS vs three Gouffon screws36①②③④
Madsen 1987 [20]DenmarkRCT75(25-91)/74(34-92)51/5225/78SHS vs Cancellous screws24②④
Christie 1988 [21]ScotlandRCT69(26-80)61/66-SHS vs double pin33②④
Siavashi 2015 [22]IranRCT30(18-59)/28(18-60)30/2846/12DHS vs Cancellous screws12 to 36③④
Kuokkanen 1991 [23]FinlandRCT60/72.517/16-SHS vs three cancellous screws24
Chen 2017 [24]ChinaRetrospective58.3±9.3 /56.8±8.642/4438/48DHS vs Cannulated compression screw24 to 36②③
Hoshino 2016 [25]USARetrospective40±12/39±1148/1541/21DHS vs Pauwel screws4 to 66②③④
Bisaccia 2018 [26]ItalyRetrospective67.8(45-80)42/7540/77DHS vs cannulated screws12②③④
Stiasny 2008 [27]DenmarkRetrospectiveNA(30-95)44/7041/71DHS vs 3 AO screw21.5
Tolga 2012 [28]TurkeyRetrospective46(25-67)/45(18-68)33/3335/31DHS vs Cancellous screws33.6②③④

SHS sliding hip screws, DHS dynamic hip screws, RCT randomized clinical trial; ①Mortality②Non-union③AVN④Revision

Fig. 2

Quality assessment of risk of bias in the studies included

Table 2

Risk of bias assessment using the Newcastle–Ottawa Scale for cohort studies included in a meta-analysis

StudySelectionComparabilityOutcomeTotal score
Exposed cohortNon-exposed cohortAscertainment of exposureOutcome of interestThe most important factorAdditional factorAssessment of outcomeLength of follow upAdequacy of follow up
Lee 2007 [9]9
Widhalm 2019 [10]9
Chen 2017 [24]9
Hoshino 2016 [25]8
Bisaccia 2018 [26]8
Stiasny 2008 [27]7
Tolga 2012 [28]7
Flow diagram of the selection process of the studies included for the meta-analysis Characteristics of the studies included SHS sliding hip screws, DHS dynamic hip screws, RCT randomized clinical trial; ①Mortality②Non-union③AVN④Revision Quality assessment of risk of bias in the studies included Risk of bias assessment using the Newcastle–Ottawa Scale for cohort studies included in a meta-analysis

Mortality

Mortality at the last follow-up was reported in six studies [9, 10, 17, 23, 26, 27] including 1842 hips (947 for DHS and 895 for CS). The follow-up period of included studies varied from 12 to 36 months. With low heterogeneity (p = 0.24, I2 = 26%), fixed-effect model was conducted. The mortality rate of DHS and CS methods was 17.3% and 16.5%, respectively, but there was no significant difference between these two methods (Fig. 3).
Fig. 3

Forest plot of odds ratio with confidence intervals for mortality

Forest plot of odds ratio with confidence intervals for mortality

Non-union

Thirteen studies [9, 10, 15, 17–19, 22–28] enrolled 2450 hips (1245 for DHS and 1205 for CS) which reported the non-union rate. The follow-up period of included studies varied from 4 to 66 months. There results indicated no significant differences between the DHS and CS treatment (OR 1.10; 95% CI 0.81–1.48; p = 0.55). Lower heterogeneity was found (I2 = 43%; p = 0.05), and fixed-effect model was conducted (Fig. 4).
Fig. 4

Forest plot of odds ratio with confidence intervals for non-union

Forest plot of odds ratio with confidence intervals for non-union

AVN

Eleven studies [9, 10, 15, 17, 19, 21–23, 26–28] included AVN rate. The follow-up period of included studies varied from 4 to 66 months. There was a little heterogeneity across the included 11 studies (I2 = 39%; p = 0.09). Compared with CS, the DHS has no benefit on the AVN (OR 1.33; 95% CI 0.99–1.79; p = 0.06) (Fig. 5a). In our meta-analysis, we found that a study by Hoshino [19] is different from other included studies. The hips included in DHS treatment are more than three times to CS treatment, and only 15 hips were analyzed in the CS group, which would lead to selection bias. After this study removed, a sensitive meta-analysis was conducted. The result showed the heterogeneity decreased from 39 to 0%, and the CS showed less AVN with significant difference compared with DHS treatment (OR 1.47; 95% CI 1.08–1.99; p = 0.01, I2 = 0%) (Fig. 5b).
Fig. 5

Forest plot of odds ratio with confidence intervals for AVN. a meta-analysis of AVN. b sensitive analysis of AVN

Forest plot of odds ratio with confidence intervals for AVN. a meta-analysis of AVN. b sensitive analysis of AVN

Revision rate and publication bias

Fourteen studies [9, 10, 15–17, 19–27] including 2513 hips compared the revision rate between DHS and CS treatments. The follow-up period of included studies varied from 4 to 66 months. The revision rate of DHS and CS was 15.15% and 15.25%, respectively. There was no significant difference between DHS and CS (OR 0.99; 95% CI 0.79–1.23; p = 0.91) when a fixed-model was used (I2 = 39%) (Fig. 6). Revision rate enrolled most of included sixteen studies, so publication was performed for revision rate. We found that the triangle is basically symmetrical, and no obvious publication bias existed (Fig. 7).
Fig. 6

Forest plot of odds ratio with confidence intervals for revision

Fig. 7

Publication bias of mortality

Forest plot of odds ratio with confidence intervals for revision Publication bias of mortality

Discussion

Due to the anatomical and blood supply characteristics of femoral neck and femoral head, the incidence of complications and disability after femoral neck fracture surgery are relatively high [29, 30]. Internal fixation is less invasive and cheaper, could also protect femoral head, and delay the need for future arthroplasty, so DHS or CS is commonly used for femoral neck fractures in young patients and some elderly patients [31]. However, there is no consensus on the chosen between DHS and CS. In this study, we performed a meta-analysis to compare the complications between DHS and CS for the treatment of femoral neck fractures. Our results revealed that CS is superior to DHS on AVN rate, but has similar performance on mortality, non-union, and revision rate when compared with DHS. Compared with previous systematic reviews, our study has some advantages. First, some latest studies [10, 15, 18] were not enrolled for analysis in previous study. Compared with previous studies [8, 11, 32], our study has a larger sample size, and sixteen trials in total were enrolled, which provided more strong evidence for surgeon. Second, the current study had RCTs and retrospective trials with a longer follow-up duration of 4–66 months. Third, the complications were divided into mortality, re-invention or revision, non-union, and AVN, which provided more guidance for surgeons involved in these procedures unlike that in the study by Zhang et al. [8]. In Zhang et al.’s study, AVN and non-union were combined and collectively referred to as complications. However, AVN and non-union are obviously different and critical adverse events, and a subgroup and sensitive analysis is necessary. In our sensitive analysis, we found that the incidence of AVN rate is lower in CS treatments when compared with those in DHS treatment. Our findings were basically consistent with current trends. For mortality, previous studies have reported that the mortality rate of DHS/CS ranged from 0 to 40% [26, 27], and no significant difference between those two treatment. We considered that the reason for the larger range may be due to the difference in sample size and follow-up time. In our study, the mortality rate of DHS and CS was 17% and 16%, respectively, which was consistent with previous conclusions [17]. For non-union, we found DHS and CS have the same non-union rate (8.6% and 8%, respectively), which was similar to previous studies [27, 28, 33]. However, we also have some different findings. For the AVN, we found that the incidence of AVN in the CS group (8.3%) was lower than that in the DHS group (9.9%), although there was no statistical difference between them in previous RCTs or meta-analysis [8, 23, 27]. In our meta-analysis, a study by Hoshino et al. [19] reported that AVN rate for CS was 33%, in which the incidence was much higher than that reported by other studies, which may be related to the different surgeon. We conducted sensitive analysis by excluded this study, and the AVN rate in the CS group was significantly lower than that in the DHS group with heterogeneity decreased from 39 to 0%. We consider that the main reason for this is the advantage of expanded sample size, and two large sample studies support our point of view [10, 17]. We considered that the lower AVN rate in CS group was related to less invasive, which protected the blood supply as much as possible [6, 8]. In addition, the incidence rate of AVN would be significantly different and depend on displacement of the femoral neck at the time of the injury, and the AVN in displaced fracture was obvious higher than that in the non-displaced fracture [15]. For another outcome, revision was defined as any reason that required internal fixation, hemiarthroplasty, or total hip replacement (THA). Previous studies used reoperation rate for analysis; however, reoperation includes various reasons such as infection and other factors requiring reoperation. Our study used revision rate for meta-analysis, which is helpful to compare the incidence of internal fixation and hemiarthroplasty/THA between the two surgical methods in more detail. Mohamed et al. [11] reported that the reoperation rate of DHS and CS is equivalent, while Zhang et al. [8] thought that the reoperation rate of DHS is lower than CS. However, we found that a study [34] included by Zhang et al. needed careful consideration because Targon Femoral Neck and DHS are obviously different. Limitations were also existed in our study. First, non-English language studies as well as studies that could not obtain full text were not included in this meta-analysis, which could lead to selection bias. Second, previous study reported DHS and CS were also different for displaced and non-displaced fractures. The DHS has slight advantages for the management for displaced femoral neck fractures. However, due to the lack of detailed information of included study, we could not make subgroup analysis to compare the difference between the two treatment methods for displaced/non-displaced fractures. Third, the treatment methods of CS group were not completely consistent, some are two cannulated screws and some are three cannulated screws, which might have unpredictable bias. Forth, the age and fracture type could affect the mortality and development of AVN, respectively. However, many studies included in this meta-analysis include all ages and different fracture types (displaced and non-displaced hips). In a word, further analysis is required to provide stronger evidence for clinical treatment.

Conclusion

DHS and CS have similar complication including mortality, revision rate, and non-union, but CS has superior to DHS on ANV. In future, more and more study needed to provide strong evidence because of some limitation existed in this study.
  34 in total

1.  Internal fixation of femoral neck fractures. Dynamic Hip and Gouffon screws compared in 73 patients.

Authors:  J L Sørensen; J E Varmarken; J Bømler
Journal:  Acta Orthop Scand       Date:  1992-06

2.  Results of internal fixation of Pauwels type-3 vertical femoral neck fractures.

Authors:  Martyn J Parker
Journal:  J Bone Joint Surg Am       Date:  2009-02       Impact factor: 5.284

3.  Dhs plus anti-rotational screw vs cannulated screws for femoral neck fractures: an analysis of clinical outcome and incidence regarding avn.

Authors:  Michele Bisaccia; Paolo Ceccarini; Giuseppe Rinonapoli; Lorenzo Maria Di Giacomo; Julien Teodori; Andrea Schiavone; Cristina Ibanez Vicente; Giuseppe De Trana; Auro Caraffa
Journal:  Acta Orthop Belg       Date:  2018-09       Impact factor: 0.500

4.  the Targon femoral neck hip screw versus cannulated screws for internal fixation of intracapsular fractures of the hip: a randomised controlled trial.

Authors:  X L Griffin; N Parsons; J Achten; M L Costa
Journal:  Bone Joint J       Date:  2014-05       Impact factor: 5.082

5.  Fixation of displaced femoral neck fractures in young adults: Fixed-angle devices or Pauwel screws?

Authors:  C M Hoshino; M W Christian; R V O'Toole; T T Manson
Journal:  Injury       Date:  2016-03-17       Impact factor: 2.586

6.  Complications of femoral neck fracture in young adults.

Authors:  D K Dedrick; J R Mackenzie; R E Burney
Journal:  J Trauma       Date:  1986-10

Review 7.  Multiple cannulated screws vs. dynamic hip screws for femoral neck fractures : A meta-analysis.

Authors:  Lei Lei Zhang; Ying Zhang; Xianghao Ma; Youwen Liu
Journal:  Orthopade       Date:  2017-11       Impact factor: 1.087

8.  How do Orthopedic Surgeons Manage Displaced Femoral Neck Fracture in the Middle-Aged Patient? Brazilian Survey of 78 Orthopaedic Surgeons.

Authors:  Vincenzo Giordano; Marcos Giordano; Rodrigo Aquino; João Otávio Grossi; Hudson Senna; Hilton Augusto Koch
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2019-06-27

9.  A Comparison of Dynamic Hip Screw and Two Cannulated Screws in the Treatment of Undisplaced Intracapsular Neck Fractures-Two-Year Follow-Up of 453 Patients.

Authors:  Harald Kurt Widhalm; Richard Arnhold; Hannes Beiglböck; Alexandru Munteanu; Nikolaus Wilhelm Lang; Stefan Hajdu
Journal:  J Clin Med       Date:  2019-10-12       Impact factor: 4.241

10.  Comparative study of multiple cancellous screws versus sliding hip screws in femoral neck fractures of young adults.

Authors:  Mayank Gupta; R-K Arya; Satish Kumar; Vijay-Kumar Jain; Skand Sinha; Ananta-Kumar Naik
Journal:  Chin J Traumatol       Date:  2016-08-01
View more
  7 in total

Review 1.  Surgical treatment options for femoral neck fractures in the elderly.

Authors:  Boris A Zelle; Luis M Salazar; Shain L Howard; Kisan Parikh; Hans-Christoph Pape
Journal:  Int Orthop       Date:  2022-02-21       Impact factor: 3.075

2.  Comparison Between Femoral Neck Systems and Cannulated Cancellous Screws in Treating Femoral Neck Fractures: A Meta-Analysis.

Authors:  Peng Tian; Lan Kuang; Zhi-Jun Li; Gui-Jun Xu; Xin Fu
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-07-06

3.  Multiple cannulated screw fixation of femoral neck fractures with comminution in young- and middle-aged patients.

Authors:  Zhe Han; Wumti Taxi; Haobo Jia; NengNeng Ji; DongDong Cao; Xiang Sun; Chao Han; Mengqi Xie; Xinlong Ma; Qiang Dong
Journal:  J Orthop Surg Res       Date:  2022-05-18       Impact factor: 2.677

4.  A Comparative Analysis of Femoral Neck System and Three Cannulated Screws Fixation in the Treatment of Femoral Neck Fractures: A Six-Month Follow-Up.

Authors:  Ya-Zhong Zhang; Yan Lin; Chao Li; Xi-Jun Yue; Gao-Yu Li; Bin Wang; Yun-Qing Wang; Zi-Qiang Zhu
Journal:  Orthop Surg       Date:  2022-02-18       Impact factor: 2.071

5.  A Novel 3D-Printed Device for Precise Percutaneous Placement of Cannulated Compression Screws in Human Femoral Neck Fractures.

Authors:  Cheng Long; Jin-Hai Liu; Xiang-Ping Chai; Xiang-Feng Liu; Zhi-Xi Duan
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

6.  Comparing Perioperative Outcome Measures of the Dynamic Hip Screw and the Femoral Neck System.

Authors:  Marcel Niemann; Karl F Braun; Sufian S Ahmad; Ulrich Stöckle; Sven Märdian; Frank Graef
Journal:  Medicina (Kaunas)       Date:  2022-02-26       Impact factor: 2.430

7.  Enhanced interfragmentary stability and improved clinical prognosis with use of the off-axis screw technique to treat vertical femoral neck fractures in nongeriatric patients.

Authors:  Dajun Jiang; Shi Zhan; Qianying Cai; Hai Hu; Weitao Jia
Journal:  J Orthop Surg Res       Date:  2021-07-31       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.